跳至主要内容
临床试验/NCT00785135
NCT00785135终止不适用

Effects of Vertical Prism on the Symptoms of Dizziness, Headache and Anxiety as Caused by Vertical Heterophoria: A Randomized, Double-blinded, Placebo-controlled, Cross-over Study

Vision Specialists of Birmingham2 个研究点 分布在 1 个国家目标入组 13 人开始时间: 2008年11月1日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
发起方
入组人数
13
试验地点
2
主要终点
Evidence of change / improvement of symptoms of headache, dizziness and anxiety as demonstrated by validated, self-administered survey tools for these symptoms

研究概览

简要总结

The purpose of this study is to demonstrate whether, in patients diagnosed with Vertical Heterophoria, the symptoms of dizziness, headache and / or anxiety are reduced or eliminated when a kind of correction called vertical prism is added to the patient's normal eye glass prescription.

The experiment will involve giving the patient two pairs of glasses (one pair containing the baseline prescription with vertical prism (Standard Treatment Glasses) and the other pair containing the baseline prescription but without vertical prism (Placebo Glasses)) to demonstrate which pair of glasses is most effective in reducing the symptoms of dizziness, headache and / or anxiety in these patients.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Double (Participant, Care Provider)

入排标准

年龄范围
14 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • First time appointment for a patient at designated optometry office for treatment of symptoms associated with Vertical Heterophoria
  • Must have symptoms of dizziness or headache or both:
  • Dizziness defined as one or more of these: lightheadedness,dizziness, vertigo, feeling off-balance, lack of coordination / "clumsy", unsteadiness while walking or drifting / veering to one side while walking, motion sickness
  • Headache defined as one or more of these: pain anywhere in the head,posterior neck / upper trapezius (upper back), face, and in and / or around the eyes
  • Duration of symptoms greater than 4 months
  • Evaluated for these symptoms previously by at least 1 other doctor (General Practice, Family Practice, Internal Medicine, Neurology, ENT, Emergency Medicine, Pediatrics, PM&R, Ophthalmology).
  • The patient (or their representative) must be able and willing to fill out extra paperwork
  • All Patients to be seen by same Optometrist for all visits
  • Must be willing to wear glasses.
  • The patient (or their representative) must be able to sign informed consent
  • Must have a driver for Follow Up visits where Control and Treatment Glasses are dispensed, and when Washout period is initiated
  • Must have a driver for Follow Up visits where Control and Treatment Glasses are dispensed, and when Washout period is initiated
  • Must have previous negative Neuroimaging (HCT or MRI) that was ordered to assess for headache and / or dizziness

排除标准

  • Previous diagnosis of strabismus, vertical heterotropia, CN 3, 4 or 6 palsy, "lazy eye"
  • Previous eye injury or eye operation (including RK and Lasik)
  • Diagnosis of glaucoma
  • Diagnosis of cataracts
  • Diagnosis of proptosis
  • Previous C-spine surgery / fusion
  • Previous Rx contains prismatic correction
  • >18 PD of exophoria
  • > 4 PD of vertical heterophoria on Initial Exam

结局指标

主要结局

Evidence of change / improvement of symptoms of headache, dizziness and anxiety as demonstrated by validated, self-administered survey tools for these symptoms

时间窗: Survey tools administered at baseline, 5-7 days after wearing the first pair of glasses, 5-7 days after wearing the second pair of glasses, and when treatment is completed

次要结局

  • Evidence that a new survey tool developed by the authors to assess changes / improvement in dizziness, headache and anxiety associated with Vertical Heterophoria correlates to validated, self-administered survey tools for these same symptoms(New survey tool to be administered at baseline, 5-7 days after wearing the first pair of glasses, 5-7 days after wearing the second pair of glasses, and when treatment is completed)

研究者

发起方
Vision Specialists of Birmingham
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验